HC
PFE icon

Hurley Capital’s Pfizer PFE Stock Holding History

Hurley Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.8K Buy
1,738
+168
+11% +$4.47K 0.03% 176
2025
Q4 		$39.1K Buy
1,570
+4
+0.3% +$101 0.02% 190
2025
Q3 		$39.9K Sell
1,566
-657
-30% -$16.2K 0.02% 218
2025
Q2 		$53.9K Buy
2,223
+801
+56% +$18.7K 0.04% 151
2025
Q1 		$36K Sell
1,422
-1,793
-56% -$46.9K 0.03% 202
2024
Q4 		$86.3K Buy
+3,215
New +$87.2K 0.07% 102

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Hurley Capital's PFE Position: Q1 2026 in Review

Hurley Capital increased its Pfizer (PFE) stake by 11% in Q1 2026, buying an estimated $4.47K and bringing the position to 1,738 shares worth $48.8K. The position accounts for 0.03% of the portfolio, ranked #176.

Hurley Capital first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $86.3K in Q4 2024. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Hurley Capital held 1,738 shares of Pfizer worth $48.8K as of Q1 2026.
  • Hurley Capital bought 168 Pfizer shares in Q1 2026, an estimated $4.47K.
  • Pfizer made up 0.03% of Hurley Capital's portfolio in Q1 2026, its #176 holding.
  • Hurley Capital first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • Hurley Capital's Pfizer position peaked at $86.3K in Q4 2024.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Hurley Capital's 13F filing for Q1 2026, filed 6 May 2026.